Technology: Cell-based gene therapy
Industry: PharmTech, Public
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2015-01-01
Employees Number: 101-250
Funding Status: M&A
Investors Number: 14
Total Funding: 173300000
Estimated Revenue: $10M to $50M
Last Funding Date: 2018-03-21
Last Funding Type: Series B

Visit Website
info@tcr2.com
Register and Claim Ownership